Latest Biotech News

Recent progress in targeted cancer therapies highlights menin inhibitors as transformative agents for treating acute leukemias harboring KMT2A gene rearrangements and related mutations. Menin, a...

A new photonics study reveals a novel phenomenon wherein photoluminescence emissions exhibit high momentum two-dimensional propagation facilitated by coupling with surface lattice resonances...

Researchers from a collaborative team in China and Singapore have achieved a landmark breakthrough by synthesizing and characterizing a cerium–carbon triple bond stabilized within an endohedral...

Novo Nordisk's new amylin-targeting obesity drug, amycretin, demonstrated significant weight loss in a Phase 1/2 study, with the highest dose group losing an average of 24.3% body weight over 36...

Vertex Pharmaceuticals reported that their investigational off-the-shelf stem cell therapy, zimislecel (previously VX-880), enabled 10 out of 12 type 1 diabetes patients to stop insulin therapy...

Recent organizational changes within the U.S. FDA have led to the administrative leave and departure of top leadership in the Center for Biologics Evaluation and Research's Office of Therapeutic...

Recent innovations in artificial intelligence are dramatically accelerating biology and drug development. KAIST researchers have improved text-to-image generative models to generate more creative,...

Scientists at Xi’an Jiaotong-Liverpool University and Nanjing University have engineered a novel nanoparticle system integrating the biodegradable polymer PLGA with blood protein albumin to form...

New studies illuminate molecular mechanisms central to Parkinson’s disease (PD). Investigations reveal that parkin-deficient human dopaminergic neurons derived from iPSCs generate α-synuclein...

Gilead Sciences attained FDA approval for Yeztugo (lenacapavir), the first twice-yearly injectable pre-exposure prophylaxis (PrEP) drug for HIV prevention. Clinical trials demonstrated up to 100%...

A pioneering study demonstrates that extracts from the human amniotic membrane (hAME) significantly potentiate the anti-cancer efficacy of doxorubicin in neuroblastoma cells by impeding...

A transformative immunotherapy approach enables in vivo generation of chimeric antigen receptor (CAR) T cells directly within patients using antibody-conjugated lipid nanoparticles (tLNPs). These...

Researchers have achieved a landmark synthesis of a cerium–carbon triple bond encapsulated inside an endohedral fullerene, specifically a Ce≡CSc2 cluster within a C80 carbon cage. This work,...

The U.S. Food and Drug Administration (FDA) has initiated a pilot program led by Commissioner Martin Makary aimed at streamlining and accelerating the drug review process for medicines addressing...

Recent discoveries have provided new insights into molecular mechanisms underlying Alzheimer's and Parkinson's diseases. Researchers have elucidated the pivotal role of α2,6-sialylation in...

Significant progress is underway in cancer research focusing on acute leukemias, colorectal cancer, and drug resistance mechanisms. A novel therapeutic target combining histone acetyltransferases...

Emerging artificial intelligence (AI) and computational frameworks are revolutionizing biotechnological research and healthcare. At the 2025 BIO International Convention, novel AI-driven drug...

Pediatric and neonatal care is witnessing critical advancements addressing infectious diseases, developmental challenges, and therapeutic monitoring. Studies in neonatal intensive care units have...

The pharmaceutical field is seeing remarkable progress in drug delivery and synthesis methodologies. A novel nanoparticle system combining PLGA polymer with albumin exhibits ultrahigh colloidal...

Cutting-edge research links microbiome composition and environmental chemical monitoring to health outcomes. Studies reveal gut microbiota's influence on cardiac health in breast cancer patients,...